These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9723452)

  • 1. Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction.
    Islam MS; Francos GC; Dunn SR; Burke JF
    Transplant Proc; 1998 Aug; 30(5):2230-1. PubMed ID: 9723452
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
    Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
    Park JH; Park JH; Yang CW; Kim YS; Kim SY; Moon IS; Koh YB; Bang BK
    Transplant Proc; 2000 Nov; 32(7):1747. PubMed ID: 11119917
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
    Tsang WK; Tong KL; Yeung S; Lee W; Chan HW
    Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
    Altaca G; Berber I; Aydin C; Yigit B; Aydin M; Titiz I
    Transplant Proc; 2001; 33(7-8):3248-9. PubMed ID: 11750391
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease.
    Weir MR; Fink JC; Hanes DS; Gardner J; Klassen DK; Cangro C; Schweitzer E; Bartlett ST
    Transplant Proc; 1999; 31(1-2):1286-7. PubMed ID: 10083574
    [No Abstract]   [Full Text] [Related]  

  • 10. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
    Suhail SM; Vathsala A; Lou HX; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX; Vathsala A
    Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M; Pourmand G; Mehrsai AR; Mansoori D
    Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
    Kliem V; Boeck A; Eisenberger U; Petersen R; Radermacher J; Hiss M; Pethig M; Koch KM; Nashan B; Brunkhorst R
    Transplant Proc; 1999; 31(1-2):1312-3. PubMed ID: 10083586
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
    Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 19. Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Türk H; Böhler T; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2229. PubMed ID: 9723451
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate mofetil decreases the risk for chronic renal allograft failure.
    Meier-Kriesche H; Ojo AO; Arndorfer JA; Magee JC; Cibrik DM; Leichtman AB; Campbell DA; Kaplan B
    Transplant Proc; 2001; 33(1-2):1005-6. PubMed ID: 11267165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.